Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 07:00PM GMT
Release Date Price: €67.5 (-0.74%)
Ruizhi Qin
JPMorgan Chase & Co, Research Division - Analyst

All right. Good afternoon, everyone. Hope you've all been enjoying the conference so far. I'm Julia Qin from the Life Science team at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Bio-Techne. Just as a reminder, if you'd like to ask a question, you can use the feature on the website. And with that, let me turn it over to Chuck.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Thanks, Julia. Well, welcome, everybody. We're glad to be here. This is our seventh invite in a row, 7 years at this conference. And we're excited to be here yet again and not be walking around the ring out in San Francisco, so it's all good. I'm going to advance my slides here on paper, and you'll be able to follow along electronically. I'll try to remember to tell you what slide and probably I'd be doing this all day.

Slide 1 is the safe harbor. Of course, that's meant to tell you about forward-looking statements and remind you that you can go

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot